File: b-be-02-b7-fiche-dinformation-destinee-au-public.pdfTrial reference: Phase II study evaluating the clinical efficacy of TG4010 (MVA-MUC1-IL2) in patients with metastatic Renal Cell Carcinoma (RCC) Doc type: Information for the public
